CATEGORIES

Press Release

LATEST

TRENDING

EDITORS CHOICE

Treatment for Schizophrenia and Bipolar I Disorder Gets Vote of Support

The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

Anthem Foundation and March of Dimes Address Health Inequity in Maternal Healthcare

March of Dimes and Anthem Foundation, the philanthropic arm of Anthem, Inc., today announced a $1.1 million grant with their latest plans to tackle America's maternal and infant health crisis

FDA approves Ready-to-Use Ephedrine Injection, Emerphed™

Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial)

Private Practice: Solution Mode to Survival Mode

A true glimpse into the process of transitioning a practice and how it can be a great solution to the issues facing private practices. Many are struggling,